Divis Laboratories Ltd.
| BSE: 532488 | Sector: Health care |
| NSE: DIVISLAB | ISIN Code: INE361B01024 |
| BSE 00:00 | 05 May | 4035.25 |
47.85 (1.20%) |
OPEN
4000.00 |
HIGH
4064.35 |
LOW
3973.40 |
| NSE 00:00 | 05 May | 4035.45 |
50.10 (1.26%) |
OPEN
3999.00 |
HIGH
4064.55 |
LOW
3975.00 |
| OPEN | 4000.00 |
| PREVIOUS CLOSE | 3987.40 |
| VOLUME | 35433 |
| 52-Week high | 4064.35 |
| 52-Week low | 2094.60 |
| P/E | 57.64 |
| Mkt Cap.(Rs cr) | 107,116 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Divis Laboratories Ltd. (DIVISLAB) - Latest News & Headlines
-
Top trading ideas by Bharat Gala of Ventura Sec: Buy Nocil, Divi's Labs
8.58 am | 3 May 2021 | Business Standard
Recently, the stock of Divi's Labs has given a weekly range breakout, making a new high of 4133, supported by volumes
-
Here is a Bull Spread Strategy on Divi's Labs by Nandish Shah of HDFC Sec
8.56 am | 30 Apr 2021 | Business Standard
The short term trend is positive where the stock is trading above its 5-, 20- and 50-day EMA
-
Trading ideas by Ajit Mishra of Religare Broking: Buy Divi's Labs, Nalco
8.27 am | 28 Apr 2021 | Business Standard
Most metal stocks are trading at their record highs and showing no sign of slowing down
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Project pipeline, ongoing expansion offer revenue visibility for Divi's
1.02 am | 9 Feb 2021 | Business Standard
Divi's Laboratories Q3 results: While top line growth was strong, margin performance stood out in the December quarter
-
Stocks to watch: BPCL, Britannia, PNB, Mrs Bectors Food, Divi's Labs, Affle
8.40 am | 8 Feb 2021 | Business Standard
PNB plans to raise Rs 3,200 crore from share sale during the current quarter to enhance its capital base
-
Stock calls by Nilesh Jain of Anand Rathi: Buy Pidilite, Godrej Industries
8.45 am | 27 Jan 2021 | Business Standard
Pidilite's stock is in a secular uptrend and has formed a bullish Harami candlestick pattern on the daily chart
-
Here is a Bull Spread Strategy on Divi's Lab by Nandish Shah of HDFC Sec
7.29 am | 18 Dec 2020 | Business Standard
Short covering was seen in the Divi's Lab Futures' where we have seen 1 per cent fall in the Open Interest with price rising by 3 per cent
-
Divi's Labs m-cap crosses Rs 1 trillion; stock zooms 109% in CY 2020 so far
10.58 am | 17 Dec 2020 | Business Standard
Currently, Divis Labs stands at the 30th position among companies having market-cap of over Rs 1 trillion.
-
Pharma shares in focus; Divi's Labs hits new high, Gland Pharma zooms 20%
11.11 am | 23 Nov 2020 | Business Standard
Dishman Carbogen Amcis, Ipca Lab, SPARC, Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in t...
-
ITC, TCS: Trading strategies for defensive stocks in a volatile session
1.22 pm | 20 Nov 2020 | Business Standard
Major stocks are showing upside bias with support from moving averages and technical parameters
-
Top stock picks by Nilesh Jain of Anand Rathi: Buy Coforge, Divis Labs
8.09 am | 13 Nov 2020 | Business Standard
The momentum indicator RSI has also breached the falling trend line and MACD provided a fresh buy crossover on the daily chart which hints of further ...
-
Infosys, PI Industries, ICICI Bank: Top picks of brokerages for Samvat 2077
2.44 pm | 11 Nov 2020 | Business Standard
According to Axis Securities, the small and midcaps are picking up steam and they should deliver solid returns in 2021 as economic uncertainties will ...
-
Divi's Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? Read on
11.50 am | 11 Nov 2020 | Business Standard
Till Nifty Pharma holds above the 11,180 mark, the bullish bias will prevail, charts suggest.
-
Divi's Laboratories surges 6%, hits a record high on strong Q2 numbers
9.57 am | 9 Nov 2020 | Business Standard
Q2FY21 EBITDA margins expanded 843 bps YoY to 42.4 per cent due to significantly better gross margin performance and lower other expenditure.
Quick Links for Divis Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
